What is McKesson's u.s. pharmaceutical — exit and other-related costs?

McKesson (MCK) reported u.s. pharmaceutical — exit and other-related costs of $1M in Q2 2025.

What is the long-term trend for McKesson's u.s. pharmaceutical — exit and other-related costs?

Over 3 years (2021 to 2024), McKesson's u.s. pharmaceutical — exit and other-related costs has grown at a -35.2% compound annual growth rate (CAGR), from $11M to $3M.

What does u.s. pharmaceutical — exit and other-related costs mean?

Expenses incurred from closing down specific operations or facilities within the U.S. Pharmaceutical segment.

Discontinued — last reported Q2 '25

Business Segments · Exit and other-related costs

U.S. Pharmaceutical — Exit and other-related costs

Over 3 years (FY 2021 to FY 2024), U.S. Pharmaceutical — Exit and other-related costs shows a downward trend with a -35.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementSegment

CategoryEfficiency

SignalLower is better

VolatilityVolatile

First reportedQ3 2019

Last reportedQ2 2025Aug 6, 2025

Rolls up toBusiness Exit Costs

How to read this metric

Higher costs indicate significant operational shifts or divestitures, which may signal a strategic pivot or consolidation.

Detailed definition

These are costs associated with exiting specific business activities, facilities, or product lines within the U.S. Pharm...

Peer comparison

Often categorized under restructuring or exit costs by large-scale distribution and logistics companies.

Metric ID: mck_segment_u_s_pharmaceutical_exit_and_other_related_costs

Historical Data

16 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q2 '25
Value	$2M	$2M	$3M	$7M	$1M	$0	$1M	$4M	$1M	$1M	$1M	$3M	$0	$0	$0	$1M
QoQ Change	—	+0.0%	+50.0%	+133.3%	-85.7%	-100.0%	—	+300.0%	-75.0%	+0.0%	+0.0%	+200.0%	-100.0%	—	—	—
YoY Change	—	—	—	—	-50.0%	-100.0%	-66.7%	-42.9%	+0.0%	—	+0.0%	-25.0%	-100.0%	-100.0%	-100.0%	—

Range$0 – $7M

CAGR-16.9%

Avg YoY Growth-58.5%

Median YoY Growth-58.3%

Similar Metrics at Other Companies

Packaging Corp of AmericaPKG View metric

Tyson FoodsTSN View metric

IDEXIEX View metric

Packaging Corp of AmericaPKG View metric

Carpenter TechnologyCRS View metric

Tyson FoodsTSN View metric

Frequently Asked Questions

What is McKesson's u.s. pharmaceutical — exit and other-related costs?: McKesson (MCK) reported u.s. pharmaceutical — exit and other-related costs of $1M in Q2 2025.
What is the long-term trend for McKesson's u.s. pharmaceutical — exit and other-related costs?: Over 3 years (2021 to 2024), McKesson's u.s. pharmaceutical — exit and other-related costs has grown at a -35.2% compound annual growth rate (CAGR), from $11M to $3M.
What does u.s. pharmaceutical — exit and other-related costs mean?: Expenses incurred from closing down specific operations or facilities within the U.S. Pharmaceutical segment.